Dr Jeffrey Quek

MBBS, MRCP (UK)

Senior Consultant

Singapore General Hospital

Specialty: Haematology

Make an Appointment

About

Education and Training

Professional Appointments and Committee Memberships

Awards

Publications

Conditions Treated By This Doctor

Acute Leukaemia Acute Lymphocytic Leukemia (ALL) Aplastic Anaemia Chronic Lymphocytic Leukemia (CLL) Chronic Myeloid Leukemia (CML) Deep Vein Thrombosis Essential Thrombocythemia and Myelofibrosis Multiple Myeloma Myelodysplastic Syndromes Myelofibrosis Polycythemia Vera Thalassaemia

Clinical Interests

Haematopoietic Stem Cell ＆ Cellular Therapy

Clinical Appointments

Senior Consultant

SingHealth Duke-NUS Blood Cancer Centre

Senior Consultant

SingHealth Duke-NUS Transplant Centre

Senior Consultant

Haematology

Senior Consultant

About

Dr Jeffrey Quek graduated from School of Medicine, National University of Singapore (NUS) in 2007. He obtained his MRCP(UK) in 2013. He underwent Senior Residency Training in Haematology in Singapore General Hospital (SGH) from 2013 to 2016. He is currently a Consultant with the Department of Haematology, SGH. He is also appointed as Member of the Medical Review Panel of the Bone Marrow Donor Programme (BMDP). He is actively involved in clinical services, clinical trials and education. His area of interests are in hematopoietic stem cell transplantation and acute leukemias.

Education and Training

MBBS
MRCP (UK)

Professional Appointments and Committee Memberships

Clinical Lecturer, Yong Loo Lin School of Medicine, National University of Singapore
Clinical Teacher, Lee Kong Chian School of Medicine
Clinical Assistant Professor, Duke-NUS Medical School
Member of the Medical Review Panel, Bone Marrow Donor Program Singapore (BMDP)
Executive Committee Member, Singapore Society of Haematology

Awards

Singhealth 10-year Long Service Award 2019
Outstanding Residency Award 2014
Outstanding Residency Award 2015
Singhealth Quality service award – Silver Award 2013-2014
Singhealth Quality service award – Gold Award 2014 – 2015
Singhealth Quality service award – Star Award 2015- 2016

Publications

Pwint K-SW, Chen Y, Diong CP, Goh Y-T, Grant D, Ho A, et al. Mobilization kinetics of peripheral blood stem cells with rescue plerixafor - real-world experience from a single center. Vol. 61, Leukemia & lymphoma. United States; 2020. p. 1740–3.
Quek J, Lee JJ, Lim FL, Diong C, Goh YT, Gopalakrishnan S, et al. Donor-type fresh frozen plasma is effective in preventing hemolytic reaction in major ABO incompatible allogeneic stem cell transplant. Transfusion. 2019 Jan;59(1):335–9.
Lee LY, Namuduri R, Chan MMF, Quek JKS, Koh MJ-A. Epstein-Barr virus positive diffuse large B-cell lymphoma presenting with vaginal sloughing and ulcerated skin nodule. Vol. 45, Journal of cutaneous pathology. United States; 2018. p. 162–6.
Acquired factor V deficiency in a patient with myeloma and amyloidosis. Quek JKS, Wong WH, Tan CW, Tha MH, Nagarajan C, Lee LH, Ng HJ. Thromb Res. 2018 Jan 31;164:1-3. doi: 10.1016/j.thromres.2018.01.045
Yeap WH, Wong KL, Shimasaki N, Teo ECY, Quek JKS, Yong HX, et al. Corrigendum: CD16 is indispensable for antibody-dependent cellular cytotoxicity by human monocytes. Sci Rep. 2017 Apr;7:46202.
Yeap WH, Wong KL, Shimasaki N, Teo ECY, Quek JKS, Yong HX, et al. CD16 is indispensable for antibody-dependent cellular cytotoxicity by human monocytes. Sci Rep. 2016 Sep;6:34310.